Eli Lilly (LLY) recently received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) for its Alzheimer's drug donanemab, underscoring the company's advancements in a ...

Port Angeles’ Day of Play, music and stage performances highlight weekend events on the North Olympic Peninsula.

Gate Bioscience Inc. has entered a collaboration and license agreement with Eli Lilly and Co. to discover, develop and ...

Eli Lilly is walking through the Gate, inking a deal worth up to $856 million with a biotech aiming to build out a new ...

Dave Hinton is editor of The News-Gazette's 'Our Communities' section. He can be reached at dhinton@news-gazette.com.

Eli Lilly (LLY) recently entered a collaboration with Gate Bioscience to develop molecular gate therapeutics, a move that ...

California’s Gate Bioscience, a biotech developing molecular gates, a new class of small molecule drugs to eliminate ...

The gene therapy developer is cutting 30% of its workforce. Elsewhere, Abivax secured a major cash infusion, while Novartis and Eli Lilly struck research deals.

Midsize U.S. metros are driving job growth, attracting talent, reshaping local economies, and offering a vibrant social scene ...

Seven biotech unicorns are advancing AI-powered drug discovery and development—but must contend with a difficult investing ...